The eXplainable Artificial Intelligence
Precision Medicine Company
Tersan Pharmaceuticals Ltd is a leading Al driven Precision Medicine Company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems.

Using its KEM® Explainable Artificial Intelligence (XAl) technology, Tersan helps its partners introduce personalized medicine clinical trial design into their protocols and identify the best clinical endpoints, the best responders and the best potential synergistic drugs. Tersan routinely collects and combines clinical data with omic data, immunological readouts (such as FACS), microbiota, Patient Reported Outcomes as well as Real World Evidence data.
MANAGEMENT TEAM

Tersan Pharmaceuticals Ltd - Img

Terence Edward Prudhoe

Chairman Board of Directors

Véronique CHABERNAUD

Chief Medical Officer
Tersan Pharmaceuticals Ltd - Img

Hichem CHAKROUN

SVP Clinical Development

Federico GOODSAID

SVP Regulatory Affairs & Quality

Bertand LELLOUCHE

Chief Financial Officer
Tersan Pharmaceuticals Ltd - Img

David MORLEY

Chief Product Officer

Frédéric Parmentier

Director of Data Science

Marion SOTO

VP Business Development
Scientific advisors

Dr. Alain COMMERÇON

Scientific Advisor

Pr. Jean-Yves BLAY

Scientific Advisor

Dr. Saeed Heusser

Chief Research Scientist

Pr. Jacques TOUCHON

Scientific Advisor
Board of directors

Tersan Pharmaceuticals Ltd - Img

Terence Edward Prudhoe

Chairman Board of Directors Tersan Pharmaceuticals Ltd

Adam AFSHAR

CEO Hyde Park Global
Daniel Bernier

Daniel BERNIER

CEO Euracier
Tersan Pharmaceuticals Ltd - Img

Sandre Jean Prudhoe

Company Secretary

Kia Motesharei

Senior Vice President of Business Development
Combining advanced data analytics with regulatory expertise, Tersan®  helps translate findings into innovative clinical plans. With a growing number of successful therapeutic development applications, KEM® is the only FDA-reviewed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine.

Tersan has developed Onco KEM®, the most advanced, clinically tested, oncology treatment selection system, Founded in 2003 as a spin-off of Institut Pasteur, Paris, France, the company operates a subsidiary in the United Kingdom since 2012.

CAREERS

Tersan Pharmaceuticals Ltd is growing fast, and we are seeking individuals for the following open positions in our Paris office

Data Scientist / Biostatisticien(ne) / Biostatistician